Table: Hisamitsu -2015/16 parent results
Apr 8 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 29, 2016 Feb 28, 2015 Feb 28, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 119.31 119.97
(-0.6 pct) (-3.2 pct)
Operating 25.69 26.31
(-2.4 pct) (-7.8 pct)
Recurring 26.30 27.84
(-5.5 pct) (-6.1 pct)
Net 16.93 18.41
(-8.1 pct) (-17.2 pct)
EPS 198.71 yen 214.88 yen
EPS Diluted 198.65 yen
Ann Div 81.00 yen 80.00 yen 81.00 yen
-Q2 Div 40.00 yen 37.50 yen 40.50 yen
-Q4 Div 41.00 yen 42.50 yen 40.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO